These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 15381545)

  • 41. Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations.
    Bayoumi W; Fontas E; Sillard L; Le Duff F; Ortonne JP; Bahadoran P; Lacour JP; Passeron T
    Br J Dermatol; 2012 Jan; 166(1):208-11. PubMed ID: 21824124
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines.
    Grimes PE; Morris R; Avaniss-Aghajani E; Soriano T; Meraz M; Metzger A
    J Am Acad Dermatol; 2004 Jul; 51(1):52-61. PubMed ID: 15243524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time-kinetic study of repigmentation in vitiligo patients by tacrolimus or pimecrolimus.
    Lubaki LJ; Ghanem G; Vereecken P; Fouty E; Benammar L; Vadoud-Seyedi J; Dell'Anna ML; Briganti S; Picardo M; Heenen M
    Arch Dermatol Res; 2010 Mar; 302(2):131-7. PubMed ID: 19547993
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.
    Hamzavi I; Jain H; McLean D; Shapiro J; Zeng H; Lui H
    Arch Dermatol; 2004 Jun; 140(6):677-83. PubMed ID: 15210457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo.
    Goktas EO; Aydin F; Senturk N; Canturk MT; Turanli AY
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):553-7. PubMed ID: 16684283
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis.
    Taibjee SM; Cheung ST; Laube S; Lanigan SW
    Br J Dermatol; 2005 Nov; 153(5):960-6. PubMed ID: 16225606
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P; Klahan SO
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 308-nm excimer lamp vs. 308-nm excimer laser for treating vitiligo: a randomized study.
    Le Duff F; Fontas E; Giacchero D; Sillard L; Lacour JP; Ortonne JP; Passeron T
    Br J Dermatol; 2010 Jul; 163(1):188-92. PubMed ID: 20346025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo.
    van Geel N; Ongenae K; De Mil M; Haeghen YV; Vervaet C; Naeyaert JM
    Arch Dermatol; 2004 Oct; 140(10):1203-8. PubMed ID: 15492182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
    Coskun B; Saral Y; Turgut D
    Eur J Dermatol; 2005; 15(2):88-91. PubMed ID: 15757818
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study.
    Nordal EJ; Guleng GE; Rönnevig JR
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1440-3. PubMed ID: 21466589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
    Trott J; Gerber W; Hammes S; Ockenfels HM
    Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)--a prospective study.
    Lahiri K; Malakar S; Sarma N; Banerjee U
    Int J Dermatol; 2006 Jun; 45(6):649-55. PubMed ID: 16796620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study.
    Kawalek AZ; Spencer JM; Phelps RG
    Dermatol Surg; 2004 Feb; 30(2 Pt 1):130-5. PubMed ID: 14756638
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topical pimecrolimus in the treatment of vitiligo.
    Boone B; Ongenae K; Van Geel N; Vernijns S; De Keyser S; Naeyaert JM
    Eur J Dermatol; 2007; 17(1):55-61. PubMed ID: 17324829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of the 308-nm excimer laser and a 308-nm excimer lamp with 311-nm narrowband ultraviolet B in the treatment of psoriasis.
    Köllner K; Wimmershoff MB; Hintz C; Landthaler M; Hohenleutner U
    Br J Dermatol; 2005 Apr; 152(4):750-4. PubMed ID: 15840108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Optimal frequency of treatment with the 308-nm excimer laser for vitiligo on the face and neck.
    Shen Z; Gao TW; Chen L; Yang L; Wang YC; Sun LC; Li CY; Xiao Y; Liu YF
    Photomed Laser Surg; 2007 Oct; 25(5):418-27. PubMed ID: 17975956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction of clinical response to excimer laser treatment in vitiligo by using neural network models.
    Cazzaniga S; Sassi F; Mercuri SR; Naldi L
    Dermatology; 2009; 219(2):133-7. PubMed ID: 19546510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calcipotriol and PUVA as treatment for vitiligo.
    Cherif F; Azaiz MI; Ben Hamida A; Ben O; Dhari A
    Dermatol Online J; 2003 Dec; 9(5):4. PubMed ID: 14996377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.